当前位置:首页 - 行情中心 - 福元医药(601089) - 财务分析

福元医药

(601089)

  

流通市值:33.41亿  总市值:78.10亿
流通股本:2.05亿   总股本:4.80亿

福元医药(601089)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润4.04亿元,每股收益0.85元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益346810.49万元,未分配利润132546.53万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产453665.40万元,负债106854.91万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入2,547,022,297.141,655,495,417.22802,722,388.573,339,636,352.62
营业总成本2,143,616,163.41,362,185,010.9671,053,272.622,805,736,964.07
营业利润435,280,857.09319,042,294.69148,380,642.31552,009,967.45
利润总额433,303,595.87318,619,561.42148,027,971.25549,151,061.17
净利润404,081,251.12292,438,727.97133,524,586.6492,336,741.15
其他综合收益----
综合收益总额404,081,251.12292,438,727.97133,524,586.6492,336,741.15
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计3,118,552,756.373,090,659,828.553,207,420,793.263,328,740,564.81
非流动资产合计1,418,101,246.711,346,177,998.831,286,488,414.511,219,049,736.98
资产总计4,536,654,003.084,436,837,827.384,493,909,207.774,547,790,301.79
流动负债合计1,018,132,717.88987,179,334.85963,856,813.12998,375,562.87
非流动负债合计50,416,383.5564,540,446.9168,796,569.8272,875,632.87
负债合计1,068,549,101.431,051,719,781.761,032,653,382.941,071,251,195.74
归属于母公司股东权益合计3,456,850,886.683,375,177,940.943,452,185,860.683,468,416,436.9
股东权益合计3,468,104,901.653,385,118,045.623,461,255,824.833,476,539,106.05
负债和股东权益合计4,536,654,003.084,436,837,827.384,493,909,207.774,547,790,301.79
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计2,587,517,831.851,723,816,059.83863,597,324.973,309,139,215.24
经营活动现金流出小计2,097,513,437.781,377,582,240.81719,714,280.452,753,238,603.14
经营活动产生的现金流量净额490,004,394.07346,233,819.02143,883,044.52555,900,612.1
投资活动现金流入小计1,161,023,838.779,807,7428,571,117.5391,556,477.66
投资活动现金流出小计2,729,547,410.291,242,818,231.6599,900,685.86777,213,230.61
投资活动产生的现金流量净额-1,568,523,571.52-1,233,010,489.65-91,329,568.36-385,656,752.95
筹资活动现金流入小计49,900,00049,900,00039,900,00055,000,000
筹资活动现金流出小计502,095,113452,930,887.65201,298,217.07261,682,820.72
筹资活动产生的现金流量净额-452,195,113-403,030,887.65-161,398,217.07-206,682,820.72
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-1,530,714,290.45-1,289,807,558.28-108,844,740.91-36,438,961.57
期末现金及现金等价物余额973,786,073.631,214,692,805.82,395,655,623.172,504,500,364.08
最新报告期:2024-10-25
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
太平洋周豫1.081.231.372024-10-25
浙商证券孙建,郭双喜1.031.131.292024-08-21
TOP↑